CircRNAs Regulate Senescence-Associated miRNAs in Gastric Cancer.

IF 3.5 4区 医学 Q3 ONCOLOGY
Shiyu Chen, Xiaoyan Yang, Xiaoyong Lei, Huifang Tang
{"title":"CircRNAs Regulate Senescence-Associated miRNAs in Gastric Cancer.","authors":"Shiyu Chen, Xiaoyan Yang, Xiaoyong Lei, Huifang Tang","doi":"10.2174/0115680096365738250618201121","DOIUrl":null,"url":null,"abstract":"<p><p>Gastric cancer is closely associated with the aging process, with its incidence and mortality rates significantly increasing with age, peaking around 85 years. Despite advance-ments in treatment modalities, current diagnostic and therapeutic approaches remain insuffi-cient, resulting in persistently low five-year survival rates among patients. The expanding global population and the intensifying aging process are anticipated to exacerbate the global burden of gastric cancer further, underscoring the urgency of exploring novel therapeutic strat-egies. A complex relationship exists between gastric cancer and cellular senescence, although the precise mechanisms remain incompletely understood. Cellular senescence is prevalent in gastric cancer treatment, typically serving as a natural anti-tumor barrier by inhibiting the un-controlled proliferation and malignant transformation of cancer cells. However, prolonged cel-lular senescence may trigger the secretion of pro-inflammatory factors, thereby promoting tu-morigenesis and progression. A systematic analysis of existing research data has revealed sig-nificant intersections between therapeutic targets for gastric cancer and senescence-associated signaling pathways, suggesting that modulating these critical nodes may constitute a pivotal mechanism for exploring novel therapeutic strategies bridging gastric cancer treatment and se-nescence. Circular RNAs (circRNAs) have garnered considerable attention with the advance-ment of bioinformatics and high-throughput sequencing technologies. As key regulatory fac-tors, circRNAs can modulate microRNAs (miRNAs) through a \"sponge adsorption\" mecha-nism, thereby influencing the post-transcriptional modification of critical genes. Given their high structural stability and widespread distribution in vivo, circRNAs have emerged as ideal candidate molecules for biomarkers and therapeutic targets in gastric cancer. This review fo-cuses on the mechanisms by which circRNAs, through sponging miRNAs, regulate key nodes in therapeutic targets and senescence signaling pathways in gastric cancer.</p>","PeriodicalId":10816,"journal":{"name":"Current cancer drug targets","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current cancer drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115680096365738250618201121","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Gastric cancer is closely associated with the aging process, with its incidence and mortality rates significantly increasing with age, peaking around 85 years. Despite advance-ments in treatment modalities, current diagnostic and therapeutic approaches remain insuffi-cient, resulting in persistently low five-year survival rates among patients. The expanding global population and the intensifying aging process are anticipated to exacerbate the global burden of gastric cancer further, underscoring the urgency of exploring novel therapeutic strat-egies. A complex relationship exists between gastric cancer and cellular senescence, although the precise mechanisms remain incompletely understood. Cellular senescence is prevalent in gastric cancer treatment, typically serving as a natural anti-tumor barrier by inhibiting the un-controlled proliferation and malignant transformation of cancer cells. However, prolonged cel-lular senescence may trigger the secretion of pro-inflammatory factors, thereby promoting tu-morigenesis and progression. A systematic analysis of existing research data has revealed sig-nificant intersections between therapeutic targets for gastric cancer and senescence-associated signaling pathways, suggesting that modulating these critical nodes may constitute a pivotal mechanism for exploring novel therapeutic strategies bridging gastric cancer treatment and se-nescence. Circular RNAs (circRNAs) have garnered considerable attention with the advance-ment of bioinformatics and high-throughput sequencing technologies. As key regulatory fac-tors, circRNAs can modulate microRNAs (miRNAs) through a "sponge adsorption" mecha-nism, thereby influencing the post-transcriptional modification of critical genes. Given their high structural stability and widespread distribution in vivo, circRNAs have emerged as ideal candidate molecules for biomarkers and therapeutic targets in gastric cancer. This review fo-cuses on the mechanisms by which circRNAs, through sponging miRNAs, regulate key nodes in therapeutic targets and senescence signaling pathways in gastric cancer.

CircRNAs在胃癌中调控衰老相关的mirna。
胃癌与衰老过程密切相关,其发病率和死亡率随着年龄的增长而显著增加,在85岁左右达到高峰。尽管治疗方式取得了进步,但目前的诊断和治疗方法仍然不足,导致患者的五年生存率持续较低。随着全球人口的增长和老龄化进程的加剧,预计胃癌的全球负担将进一步加剧,因此迫切需要探索新的治疗策略。胃癌和细胞衰老之间存在着复杂的关系,尽管其确切机制尚不完全清楚。细胞衰老在胃癌治疗中普遍存在,通常通过抑制癌细胞不受控制的增殖和恶性转化,作为天然的抗肿瘤屏障。然而,延长的细胞衰老可能触发促炎因子的分泌,从而促进肿瘤的发生和发展。对现有研究数据的系统分析揭示了胃癌治疗靶点与衰老相关信号通路之间的重要交叉点,表明调节这些关键节点可能是探索连接胃癌治疗和衰老的新治疗策略的关键机制。随着生物信息学和高通量测序技术的发展,环状rna (circRNAs)引起了人们的广泛关注。circRNAs作为关键调控因子,可以通过“海绵吸附”机制调控microRNAs (miRNAs),从而影响关键基因的转录后修饰。鉴于其高结构稳定性和在体内的广泛分布,环状rna已成为胃癌生物标志物和治疗靶点的理想候选分子。本文综述了环状rna通过海绵mirna调控胃癌治疗靶点关键节点和衰老信号通路的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current cancer drug targets
Current cancer drug targets 医学-肿瘤学
CiteScore
5.40
自引率
0.00%
发文量
105
审稿时长
1 months
期刊介绍: Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes. Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信